Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Minimalist illustration of an RNA strand and data points

May 26, 2026

Lexogen Featured in Labiotech's Beyond Biotech Podcast on AI-Driven Drug Discovery

A recent episode of the Beyond Biotech podcast features insights from Dr. Stéphane Barges, CEO of Lexogen, discussing the pivotal role of RNA sequencing in AI-driven drug discovery.In the podcast, Dr. Barges emphasizes that high-quality data tailored for AI applications is crucial for enhancing target identification and decreasing drug development failures. He advocates for datasets that are meticulously designed to address specific scientific questions, underscoring the importance of precision
A test tube with a colorful chemical solution on a lab bench

May 26, 2026

Exclusive: Ex-Palantir AI execs raise $12 million seed round for Perceptic, a startup automating drug discovery

Perceptic, a startup founded by former Palantir executives, has emerged from stealth mode with a $12 million seed funding round aimed at revolutionizing drug discovery through an end-to-end AI platform. The company, which has already garnered interest from major pharmaceutical firms, is designed to streamline the drug development process from discovery to clinical trial design.The funding round was led by Accel, with participation from Air Street Capital and Elder Gull. Although the company has
A minimalist representation of a bispecific antibody in flat design.

May 26, 2026

Biomunex Pharmaceuticals Embraces AI with Two New Strategic Collaborations

Biomunex Pharmaceuticals is enhancing its research capabilities through two new partnerships with AI-focused firms, Gordion Bioscience and Tangramed Biotech.The collaborations aim to integrate artificial intelligence into Biomunex's scientific workflows, particularly in the realm of immunotherapy development. By leveraging AI technologies, the company seeks to expedite the discovery and refinement of innovative treatments for cancer, focusing on bispecific and multi-specific antibodies.These str
A coffee cup and notebook in a cozy café setting

May 26, 2026

Digital Health Coffee Time Briefing ☕

The latest briefing on digital health highlights key advancements and funding initiatives aimed at enhancing healthcare delivery through technology.NEUVIOR Pharmaceuticals has secured over £99,000 in funding from Scottish Enterprise for its PHARMORIS program, which aims to leverage AI to optimize the identification and deployment of high-value generic medicines within the NHS. This initiative underscores the potential of AI in streamlining healthcare processes.In another development, TympaHealth
A stethoscope on a medical chart in a dimly lit hospital room

May 26, 2026

Ezovion Partners with Better to Build AI-Powered, openEHR-Driven Healthcare Ecosystem

Ezovion has teamed up with Better to create an AI-driven, openEHR-based healthcare ecosystem aimed at enhancing clinical workflows and patient care.This partnership merges Ezovion's AI-powered hospital solutions with Better's openEHR marketplace, facilitating improved operational efficiency for healthcare providers. The goal is to establish a flexible, interoperable infrastructure that supports clinicians, hospitals, and public health systems while ensuring vendor-neutral health data management.
Minimalist illustration of a DNA strand and genetic data

May 26, 2026

AI in Biotechnology: Applications, Careers, & Future Trends You Must Know

The integration of artificial intelligence (AI) in biotechnology is revolutionizing the field, impacting everything from drug discovery to personalized medicine.AI's role in biotechnology is becoming increasingly evident, as illustrated by the experiences of students like Dhriti, who leveraged AI tools to analyze complex genetic data. This not only expedited her research but also highlighted the potential of AI to enhance various aspects of biotechnology, including healthcare solutions. The adop
A minimalist illustration of a coin with a downward arrow, representing financial decline.

May 26, 2026

Irish venture capital funding slides 58%

Venture capital funding for Irish technology SMEs has experienced a significant downturn, with a reported 58% decline in the first quarter of 2026, totaling €221.7 million raised. This sharp drop follows a record-setting period last year, where funding exceeded half a billion euro.According to the latest VenturePulse survey from the Irish Venture Capital Association (IVCA) and William Fry, the life sciences sector has emerged as the leading area for investment, accounting for 54% of the total fu
A minimalist representation of a drug compound in a dark palette.

May 26, 2026

AI drug discovery deal targets faster biotech hit validation

A new partnership between Concept Life Sciences and OpenBench aims to revolutionize the early stages of drug discovery for biotech firms by leveraging artificial intelligence to streamline hit validation processes.The collaboration combines OpenBench’s AI-driven structure-based platform with Concept Life Sciences’ expertise in medicinal chemistry and validation services. This integrated approach is designed to expedite the transition from target identification to validated hit series in just six
A light bulb and plant silhouette representing biotech innovation

May 26, 2026

AI meets biotech: Europe’s new investival

Berlin is set to host bio:cap, an innovative investival focusing on the convergence of life sciences and artificial intelligence, from June 9-11, 2026. This inaugural event will gather a diverse mix of stakeholders, including investors, startups, and research institutions, at the CityCube venue.Europe's robust life sciences ecosystem, characterized by leading universities and research institutes, positions it as a frontrunner in biotechnology advancements. bio:cap aims to harness this potential
An ultrasound probe on a patient's arm in a dimly lit hospital room.

May 26, 2026

Europe PoCUS Device Industry Growth Analysis, Trends and Investment Outlook 2026-2035

The European point of care ultrasound (PoCUS) device market is projected to grow significantly, moving from an estimated USD 310.43 million in 2025 to approximately USD 593.20 million by 2035, reflecting a compound annual growth rate (CAGR) of 6.69%.This growth is primarily fueled by an increasing demand for immediate diagnostics at the bedside, the rising reliance on portable imaging technologies, and the integration of ultrasound-guided procedures across various healthcare settings. The region
A job application form on an office desk in a modern workspace.

May 26, 2026

YZi Labs launches YZi Talent to funnel AI, Web3 and biotech job openings

YZi Labs has introduced YZi Talent, a recruitment platform designed to consolidate job openings across its portfolio in Web3, artificial intelligence, and biotechnology. The initial roles include senior engineering and leadership positions at companies like predict.fun and AgriDynamics Robotics.The launch of YZi Talent aims to streamline the recruitment process by providing a centralized platform for candidates interested in opportunities that intersect these three innovative sectors. Featured p
flat design of a radiology imaging device

May 26, 2026

Jardine Matheson Expands Into Healthcare AI With I-MED Buy

Jardine Matheson is making a significant foray into healthcare AI with its acquisition of I-MED Radiology Network, a move that signals a strategic pivot for the traditionally diversified conglomerate.Valued at A$3.4 billion (US$2.4 billion), this acquisition grants Jardine access to one of Australia’s largest diagnostic imaging providers, positioning the company to leverage the burgeoning field of artificial intelligence in healthcare. Notably, the deal also secures a minority stake in Harrison.